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Abstract: Atherosclerosis is an inflammatory vascular disease that is characterized by 
progressive accumulation of cholesterol in the arterial walls and it is a major cause of 
cardiovascular disease. Issues related to the side effects of synthetic drugs have in recent times, 
led to the misuse of drugs, a lack of patient consultations, and consequently, a disruption in 
meticulous disease control. Therefore, a new insight into medicinal plants has recently emerged 
and much research has been conducted on these herbs in an attempt to prepare novel naturally 
based drugs. The aim of this review article was to scrutinize the molecular mechanisms of 
medicinal plants possessing effectiveness against atherosclerosis. To conduct the review, 
electronic searches were performed to retrieve potentially relevant publications, indexed within 
internet databases and reference textbooks concerning the effects and underlying molecular 
mechanisms of plants or their constituents used to treat atherosclerosis. Overall, medicinal plants 
facilitate atherosclerosis treatment through a variety of mechanisms which include the regulation 
of expression of inflammatory factors, stimulation of peroxisome proliferator-activated receptors 
(PPARs), inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA 
reductase), promotion of ATP-binding cassette transporter A1 (ABCA1) as well as ATP-binding 
cassette transporter G (ABCG), facilitation of adiponectin activity, reduction of sterol regulatory 
element-binding proteins (SREBPs) and antioxidant activity. An increased perception of these 
herbal mechanistic links is an important prelude to the design of novel plant based drugs.  
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1. INTRODUCTION 
An increased prevalence of hypertension and associated atherosclerosis is one of the most 
predominant causes of elevated mortality among younger age groups [1]. Atherosclerosis is an 
inflammatory vascular disease that is characterized by progressive accumulation of cholesterol in 
the arterial walls and it is a major cause of cardiovascular disease [2]. During atherosclerosis, 
two key events occur in the arterial walls: stimulation and differentiation of monocytes in the 
bloodstream, and uptake of low density lipoprotein (LDL) by macrophages to form foam cells 
that participate in the formation of atherosclerotic plaques. Adhesion molecules also contribute 
to leukocyte-endothelial interactions and monocyte leakage [3].  
Many contributory risk factors to varying degrees either directly or indirectly, play a role in the 
development of atherosclerotic changes in blood vessels. These include cigarette smoking, 
hypertension, diabetes, obesity, hypercholesterolemia, and a family history of heart disease [1]. 
Issues related to the side effects of current synthetic agents have in recent times led to the misuse 
of drugs, a lack of patient consultations and consequently, a disruption in meticulous disease 
control. Therefore, a new insight into medicinal plants has recently emerged and considerable 
research has been conducted on these herbs. The use of medicinal plants to treat diseases has 
been attracting attention since ancient times. Over recent decades, communities in many 
countries have been using alternative medicine more and more, especially phytotherapy and 
dietary supplements to treat diseases such as atherosclerosis. In addition to reducing healthcare 
costs, medicinal plants have led to some reassuring outcomes and it is expedient to use such 
plants even as adjuncts especially when current therapies fail to control the disease. In addition, 
the generally weaker side effects of medicinal plants compared to synthetic drugs warrant 
extensive research on these plants [2].  
Due to the health impact of atherosclerosis, the relative ineffectiveness and high cost of some 
conventional drugs plus their side effects, the use of medicinal plants with fewer adverse effects 
may well contribute towards improved treatment of atherosclerosis. Some of the currently used 
drugs worldwide have been developed from traditional agents with known mechanisms. 
Amassing knowledge about such drugs can serve as a starting point to screen natural isolated 
compounds and then to synthesize and develop drugs with similar structures. Research has been 
conducted on the mechanisms of action of medicinal plants used to treat atherosclerosis. Such 
studies are essential to develop new pharmaceutical formulations with improved effectiveness in 
relation to fewer side effects. The aim of the current review was to report the most effective 
medicinal plants employed to treat atherosclerosis and delineate their associated mechanisms of 
actions.  
 
 
 
2. MATERIALS AND METHODS 
To conduct this review, electronic searches were performed to retrieve potentially relevant 
publications, indexed in different internet databases, and reference textbooks to the molecular 
mechanisms of action of different plants, used to treat atherosclerosis, including inflammatory 
factors, agonists at peroxisome proliferator-activated receptors (PPARs), 3-hydroxy-3-methyl-
glutaryl-coenzyme A reductas (HMG-CoA reductase), ATP-binding cassette transporter A1 
(ABCA1), ATP-binding cassette transporter G (ABCG), adiponectin, and sterol regulatory 
element-binding proteins (SREBPs).  
 
3. RESULTS 
To date, a number of studies have been conducted on the molecular mechanisms of 
atherosclerosis and the medicinal plants that are effective against this disease. Much evidence 
has indicated that efficacy in treating atherosclerosis is mediated via several mechanisms 
including inflammation and other factors involved in the metabolism of lipids and glucose. These 
factors have been summarized in table 1 and are discussed below.    
3.1. Inflammatory factors 
At the onset of atherosclerosis, mononuclear leukocytes such as monocytes and T cells enter the 
arterial wall endothelium via a process requiring adhesion molecules. Transcription of these cell 
surface proteins is regulated by nuclear factor (NF)-κB [4]. NF-κB is a transcription factor that is 
activated when pro-inflammatory cytokines bind to their receptors at the endothelial surface. 
Binding molecules such as E-selectin, intracellular adhesion molecule-1 (ICAM-1), vascular cell 
adhesion molecule-1 (VCAM-1), and P-selectin are induced by this method. VCAM-1 is not 
only induced by stimulation of cytokines but also produced in response to pro-inflammatory 
macromolecules [5,6]. Hypercholesterolemia also causes the oxidation of lipoproteins and the 
oxidation of VCAM-1 at the aortic endothelial surface [7,8].  
At the surface of endothelial cells, ICAM-1 is induced through cytokine-dependent pathways, 
and ICAM-1 expression is increased by hemodynamic oxidative stress or hypertension; as a 
result, hypercholesterolemia and hypertension are two main risk factors for atherosclerosis that 
cause leukocyte adhesion to arteries. Adhesion is a multistep process that causes leukocytes to 
attach to artery walls. Adhesion is dependent on the reaction of E-selectin, ICAM-1, and VCAM-
1 with the endothelium [9] and inhibition of ICAM-1 and VCAM-1 in particular reduces the 
development of fatty streaks [10].   
It is necessary for leukocytes to migrate prior to binding to the vessel wall. The cell migration is 
accomplished by chemotactics including monocyte chemotactic protein-1 (MCP-1) [11]. MCP-1 
is expressed in all steps of atherosclerosis such that its decreased expression arrests 
atherosclerotic lesion growth [12].  
Macrophages play an important role in inflammation and the immune response which are 
dependent on the capacity to produce oxygen free radicals, proteases, complement factors, and 
cytokines, all of which are important in atherosclerosis. In relation to this, the differentiation of 
monocytes to macrophages is stimulated by macrophage colony-stimulating factor (M-CSF) 
[13].  
Macrophage uptake is aided by oxidatively modified lipoproteins through receptors that are 
regulated by certain cytokines such as tumor necrosis factor α (TNF-α). TNF-α, TNF-β, 
interleukin 2 (IL-2), and interferon-γ (IFN-γ) all causing activation of macrophages and 
inflammation (14]. IL-2 is produced by lesion cells and causes differentiation of T helper 1 (Th1) 
cells [15]. IFN-γ is an active immune cytokine that can activate macrophages for an 
inflammatory response [16]. Both TNF-α and IL-1 are also present in the lesions [17] and cause 
proliferation of smooth muscle cells (SMCs) [18]. The pathway of cytokine inflammation is 
activated by the expression of TNF-α, IL-1, and C-reactive protein (CRP) [19]. These cytokines 
stimulate macrophages to secrete matrix metalloproteinase 9 (MMP-9). MMP-9 causes migration 
of the SMCs in atherosclerosis and due to stimulation of inflammatory cytokines, vascular SMCs 
migrate from media to intimae and produce collagen, which induces the formation of a fibrous 
cap in the lesions [20].  
To date, various studies have been conducted on the anti-inflammatory effects of medicinal 
plants in the treatment of atherosclerosis. Notably, Lee et al., demonstrated in 2001, that 
treatment with the citrus flavonoids naringin and naringenin caused a significant decrease in 
VCAM-1 and MCP-1 in hypercholesterolemic rabbits [21]. While Suh et al., reported five years 
later that cryptotanshinone isolated from Salvia miltiorrhiza decreased the expression of MMP-9 
and NF-κB [22]. A 3-month clinical trial, demonstrated that virgin olive oil exerted an anti-
inflammatory effect and led to a decrease in CRP, IL-6, and endothelial and monocyte adhesion 
molecules in addition to chemokines in patients with atherosclerosis [23]. 
The aqueous, ethanolic, and chloroform extracts of S. miltiorrhiza inhibited MMP-9 and 
prevented the migration of human aortic smooth muscle cells. In addition, treatment with S. 
miltiorrhiza decreased the production of adhesion molecules and the fibrosis of atherosclerotic 
plaques in apolipoprotein E–deficient mice fed with high-fat diet [24]. Wang and coworkers 
(2013) showed that the use of a Bu-shen-Ning-Xin decoction initiated a decrease in the 
expression of NF-κB, monocyte chemoattractant protein 1 (MCP-1), ICAM-1, VCAM-1, and E-
selectin [25]. Moreover, an ethanolic extract of Gastredia elata displayed an inhibitory action 
against MMP-2/-9 in human umbilical vein endothelial cells [26].  
Furthermore, a Ginkgo biloba extract was found to decrease IL-1β expression and VSMC growth 
in hypercholesterolemic rabbits. In addition, 8-week treatment with this plant extract also 
decreased the expression of IL-1β, TNF-α, and IL-10 in the brains of hypercholesterolemic rats 
with atherosclerosis [27].  
 
 
3.2. Peroxisome proliferator-activated receptors (PPARs) 
 
As a chronic inflammatory disease, atherosclerosis develops due to a disruption of lipid 
metabolism. The accumulation of cholesterol-rich lipoproteins in arterial walls causes monocytes 
to bind to the endothelium and differentiate to macrophages. These macrophages play an 
important role in producing chemokines, cytokines, and reactive oxygen species (ROS) that 
trigger the early stages of lesion formation. PPARs consist of PPAR-α, β, and γ [28] and are 
expressed in the arterial walls. PPAR agonists are effective in the treatment of atherosclerosis 
[29] such that the activities of these receptors are beneficial in the arterial walls and in this 
context PPAR-γ regulates a pathway of cholesterol efflux in macrophages [30]. PPAR-γ also 
regulates CD36 expression, and both PPAR-γ and PPAR-α induce the expression of liver X 
receptor α (LXR-α) and ABCA1 [30, 31]. In addition, PPAR activators inhibit the expression of 
inflammatory genes in the macrophages [32].  
In mice with an LDL receptor deficiency, treatment with PPAR-γ agonists evokes a decrease in 
inflammatory mediators [32]. Thus, Li et al., reported in 2004 that PPAR-γ and PPAR-α ligands 
prevented lipid accumulation, and that PPAR-γ ligands decreased cholesterol esterification in 
macrophages.  
LXR-α contributes to the activity of PPAR ligands on atherosclerosis. This receptor is a regulator 
of the expression of ABCG and ABCA1 and it has been postulated that inhibiting foam cell 
formation using PPAR-α requires LXR expression. In relation to this, ABCG1 stimulates the 
removal of cholesterol from macrophages [33]. It has also been reported that soy isoflavones 
exert not only hypocholesterolemic but also anti-atherosclerotic effects by means of an elevated 
expression of both PPAR-γ and PPAR-α in rats with type 2 diabetes [34].  
It has been demonstrated that oral treatment with a Pandanus tectorius fruit extract augmented 
mRNA levels of PPAR-α and PPAR-α-regulated genes as well as AMP-activated protein kinase 
(AMPK) in the liver of hyperlipidemic hamsters. The PPAR-α-related genes in question, 
included those for acyl-CoA oxidase (ACO), carnitine palmitoyltransferase 1 (CPT1), hormone 
sensitive lipase (HSL), and lipoprotein lipase (LPL) that serve as markers of upregulation in the 
PPAR-α-related hypolipidemic pathway. In addition, transcription of PPAR-γ (insulin 
sensitivity) was shown to be increased [35].  
A further study has shown that 8-week oral treatment with an extract of Rheum undulatum 
produced an overexpression of PPAR-α and CPT1 in the liver resulting in a reduction of total 
and low density lipoprotein-cholesterol blood levels [36].  
Park et al., (2005) reported that extracts of mulberry leaf (0.5%), Korean red ginseng (0.5%), and 
banana leaf (0.5%), decreased blood glucose, insulin, triglyceride (TG), and HbA1c but they also 
increased gene expression of hepatic PPAR-α and PPAR-γ in the adipose tissue of non-insulin-
dependent diabetic mice [37]. It was similarly demonstrated that ethanolic extracts of Astragalus 
membranaceus and Pueraria thomsonii generated increased activity of PPAR-α and PPAR-γ 
[38]. Likewise, an aqueous Salacia oblonga root extract administered by oral gavage (≤ 900 
mg/kg) for 28 days in rats increased PPAR-α activity and as a consequence, it activated 
hypolipidemic pathways leading to a decrement in lipids, especially TG [39].  
Using reverse transcription polymerase chain reaction (RT-PCR) and microarray technology, it 
has been disclosed that 150 mg/kg of berberine administered over a nine week period, enhanced 
the expression of PPAR-α and LXR-α in diabetic hamsters [40]. Correspondingly, it has been 
reported in hypercholesterolemic rats that oral treatment with 50-200 mg/kg of Corni fructus 
extract on a daily basis for 10 days diminished not only the atherogenic index but also total 
cholesterol (TC) whilst simultaneously increasing the expression of PPAR-α and LXR-α [41]. 
Additionally, oral treatment of hypercholesterolemic mice with a methanolic mulberry (Morus 
alba) leaf extract for four weeks raised the hepatic gene expression of PPAR-α and 
downregulated the expression of genes involved in cholesterol biosynthesis including sterol 14α-
demethylase cytochrome P450 (CYP51) [42]. 
3.3. ATP-binding Cassette Transporter G (ABCG) and ATP-binding Cassette Transporter 
A1 (ABCA1) 
An inverse correlation between plasma high density lipoprotein (HDL) levels and the risk of 
atherosclerosis reflects the role of HDL and its receptors (generally along with Apolipoprotein 
A1 and A2 [ApoAI and ApoAII]) in receiving and transporting cholesterol. The uptake of 
additional cholesterol from macrophage foam cells by HDL and ApoAI is considered one of the 
most important protective mechanisms of HDL against atherosclerosis [43]. Studies of defects in 
human and animal HDL have indicated that the membrane lipid translocases ABCA1 and 
ABCG1, are the main markers of plasma HDL levels and they represent important protective 
factors against atherosclerosis [44-46]. ABCA1 is a prominent member of the ABC transporter 
family, and it is largely expressed in liver and tissue macrophages [47]. ABCG1, has recently 
been demonstrated to be one of the important regulators of cholesterol transport in reverse 
cholesterol transfer (RCT). RCT is an anti-atherosclerotic process and refers to the net movement 
of additional cholesterol from peripheral tissues, such as arterial wall macrophages, back to the 
liver alongside HDL formation.  
The LXRs regulating ABC transporter genes are key sub-processes involved in RCT. The most 
important members of this family are ABCA1 and ABCG1 [48,49] being the main regulators of 
cholesterol and phospholipid efflux from macrophage foam cells. ABCA1 transports these 
compounds to cholesterol-free lipoproteins stimulating formation of HDL, but ABCG1 is 
responsible for transporting cholesterol to mature HDL.  
 ABCA1 is essential to the transport of cholesterol from inside the plasma membrane and in 
maintaining equitable levels of HDL. The role of ABCA1 in exporting cell cholesterol was 
revealed when the ABCA1 gene was found to be defective in patients with Tangier disease [50]. 
In the absence of ABCA1, these patients had very low levels of HDL, could not transport 
cholesterol from the cell to ApoA1, and presented with accumulated cholesteryl ester in many 
tissues, particularly the arteries. Hence, early atherosclerosis is another complication of Tangier 
disease. Besides that, overexpression of ABCA1 in genetically modified mice leads to a 
significant decrease in the size and complexity of atherosclerotic lesions and an increased export 
of cholesterol from the cell promoting HDL biogenesis [51,52]. Thus, an ethanolic extract of 
Brazilian red propolis has been shown to stimulate the expression of PPAR-γ, LXR, and ApoA1 
in addition to the activity of ABCA1 [53]. 
Chen et al. (2013) studied the anti-atherosclerotic properties of Hibiscus salodariffa leaf extract 
which is a rich source of flavonoids. This extract increased the expression of the LXR-α/ABCA1 
pathway thereby preventing cholesterol uptake by macrophages and delaying the development of 
atherosclerosis. In addition, administration with Xuemai Ning caused an increase in ABCA1 
expression in hypercholesterolemic rabbits [54,55]. What is more, an extract of Crataegus 
pentaegyna caused a marginal increase in the expression of ABCA1 and PPAR-α in 
hypercholesterolemic rat hearts [56]. Analogously, an alcoholic extract of Allium sativum 
boosted the expression of ABCA1 in a macrophage containing culture medium [57].   
 
 3.4. 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA reductase) inhibitors 
Hypocholesterolemic drugs slow down atherosclerosis progression, and HMG-CoA reductase 
inhibitors contribute to this effect [58] such that they inhibit metalloproteinase (MMP) 
preventing the migration and proliferation of smooth muscle cells, and the accumulation of 
cholesterol in macrophages. Generally, HMG-CoA reductase inhibitors interfere with the main 
atherogenic processes that occur in the arterial walls [59]. In 2013, Yang et al. reported that oral 
treatment with gypenoside (50-200 mg/kg daily for five weeks) caused a 20-50% decrease in 
HMG-COA reductase activity with a consequent decline in cholesterol synthesis in the liver, 
alongside decreased TC, TG, glutathione peroxidase, superoxide dismutase, catalase, and 
malondialdehyde [60]. 
It has also been reported that 4-week oral treatment with a methanolic Aconitum heterophyllum 
root extract (200 and 400 mg/kg) lowered the levels of TC, TG, and ApoB in addition to raising 
serum HDL cholesterol (HDL-C) and ApoA levels in obese rats. The A. heterophyllum extract 
also decreased HMG-CoA reductase activity in the liver and subsequently, the synthesis of 
endogenous cholesterol whilst stimulating the activity of lecithin–cholesterol acyltransferase to 
generate elevated HDL-c [61].  
Jain et al. reported in 2010, that 30-day treatment of rats with ≤ 600 mg/kg of methanolic 
moringa extract induced a fall in TC and LDL cholesterol (LDL-C) levels compared to controls. 
The hypocholesterolemic effect of this plant was ascribed to the inhibition of cholesterol 
reabsorption from endogenous sources and an increased release into feces as neutral steroids. In 
addition, HMG-CoA reductase activity decreased in response to treatment with this extract [62]. 
Likewise, an ethanolic Ananas comusus leaf extract caused a decrease in TG and TC 
concentrations in hypolipidemic rats. The extract also significantly inhibited HMG-CoA 
reductase activity [63].  
Additionally, it was also shown in a study by Vaidya et al. in 2009, that 7-day treatment with  
swertiamarine (isolated from Enicostemma littorale) in rats on a high-cholesterol diet  decreased 
cholesterol and TG levels via HMG-CoA reductase inhibition and it also increased the excretion 
of bile acids and esterols [64]. In addition, in hyperlipidemic rats, pulverized Terminalia arjuna 
bark extract given by oral gavage, initiated a decrease in TC, TG, LDL-C, and very low density 
lipoprotein cholesterol (VLDL-C) in a dose-dependent manner in [65]. Moreover, oral treatment 
with 100 and 200 mg/kg of the dried pulp of Aloe vera leaf in hyperlipidemic rats produced a 
considerable decrease in TC, TG, VLDL-c, and LDL-c levels as well as the atherogenic index in 
addition to augmenting HDL-c. Besides this, the treatment instigated a substantial decrease in the 
HMG-CoA reductase activity [66].  
Brusq et al. (2006) showed that 15 µg/ml of berberine activated AMPK, a sensor of energy in 
mammalian cells. HMG-CoA reductase and acetyl-CoA carboxylase are implicated in the 
synthesis of cholesterol and fatty acids, and because they are inactivated by AMPK-mediated 
phosphorylation, the overall outcome was an inhibition of cholesterol and TG production [67]. In 
another study, it was reported that treatment with ≤ 1% of lyophilized green tea powder in rats 
fed a diet containing 6% fructose, there was a reduction in TG concentration, while fructose 
produced an increase in serum TG and TC levels. It was notable that green tea also diminished 
ABCA1 and HMG-CoA reductase gene expression [68].  
Black chokeberry (Aronia melanocarpa) extract (50 and 100 µg/ml), added to an in vitro culture 
medium containing human colorectal adenocarcinoma cells (Caco-2) decreased cholesterol 
synthesis.  There was also a drop in the gene expression for ABCA1 and HMG-CoA reductase 
and it was postulated that the hypolipidemic effects of this medicinal plant might be partly 
assigned, to increased apical efflux of LDL-derived cholesterol [69].  
 
 
3.5. Sterol regulatory element binding proteins (SREBPs) 
SREBPs are transcription factors that regulate lipid hemostasis by modifying the expression of 
enzymes necessary for the synthesis of cholesterol, TG, phospholipids, and fatty acids. 
Accordingly, they contribute to the control of atherosclerosis [70]. SREBP expression leads to 
increased vascular fatty streaks and fibrous-fatty plaques. In addition, the formation of foam cells 
in atherosclerotic lesions is associated with decreased gene expression of SREBPs [71]. Thus, a 
reduced SREBP gene expression has been observed in diabetic hamsters treated with 150 mg/kg 
of berberine for nine weeks [40] and also in rats treated with lyophilized pulverized green tea 
(0.5% and 1%) for six weeks [68]. This finding was substantiated by Kim et al. with A. 
melanocarpa extract in Caco-2 cells [69], and by Kobayashi et al. in hypercholesterolemic mice 
treated with methanolic M. alba (0.1 and 1 mg/ml) for four weeks [42]. All of these studies 
reported that lipogenic pathways in the liver were inhibited by decreasing the gene expression of 
SREBPs and it has also been concluded that the extent of LXR/PPAR/SREBP participation in 
the function of the vascular intima varies during atherogenesis with respect to the individual 
[72].  
3.6. Adiponectin 
 
Adiponectin firstly suppresses TNF-α-1 which induces the expression of adhesion molecules in 
vessel endothelial cells by inhibiting the transcription of NF-κB and subsequently, the expression 
of the pro-inflammatory cytokine IL-8 in endothelial cells [73,74]. Secondly, it represses growth 
factor causing proliferation of SMCs by inhibiting mitogen activated protein kinase [75]. Thirdly 
it inhibits foam cell formation, and the release of TNF-α by macrophages [76]. Increased 
expression of adiponectin in patients with atherosclerosis diminishes the expression of VCAM-1 
and TNF-α in the aorta, restricting the progression of atherosclerotic lesions, thereby exerting an 
anti-atherosclerotic effect [77]. On top of these actions, adiponectin augments the expression of 
anti-inflammatory cytokines and metalloproteinase inhibitors in macrophages thereby promoting 
plaque stability [78].   
Medicinal plants are effective in facilitating adiponectin activity. Examples include Momordica 
charantia [79], Allium sativum [80],  Irvingia gabonensis, Radix Astragli  [81], Astragalus 
membranaceus [82], Green tea [83] Sasa Borealis [84], Ganoderma Lucidum [85], Brassica  
rapa, Phaseolus vulgaris, Brassica rapa, Glycine max, Spinacia oleracea, Pisum sativum, 
Raphanus sativus, Arctium lappa,  Momordica Charantia, and Brassica oleracea [86]. 
3.7. Plants antioxidants and Atherosclerosis 
As mentioned earlier, hyperlipidemia is a risk factor that can accelerate the development of 
atherosclerosis and the progression of atherosclerotic lesions. It has been shown that boosting 
intracellular reactive oxygen species (ROS) enhances atherosclerosis development. 
Malondialdehyde (MDA), an oxidant stress marker, is increased during the development of 
hyperlipidemia, so that there is a correlation between hyperlipidemia and atherogenic index (AI) 
which is considered as an important risk factor for atherosclerosis. ROS are generated during 
physiological and pathophysiological oxidative metabolism in mitochondria. Both ROS and 
reactive nitrogen species (RNS) may react with various biomolecules, such as nucleic acids, 
proteins, lipids and carbohydrates to interfere with cell function. In normal physiological 
conditions, a balance exists between free radical generation and antioxidant defense systems. 
However, any imbalance in this equilibrium causes oxidative stress and this is considered as a 
component of tissue damage mechanisms in variety of human disorders including atherosclerosis 
[98]. Enzymatic and non-enzymatic antioxidants play important roles in alleviating free radical-
induced tissue damage. Serum MDA has been shown to be higher in hyperlipidemic subjects and 
regresses following antioxidant supplementation [87]. Furthermore, recently published work has 
strongly suggested a crucial role for nutritional and pharmacological approaches towards 
antioxidants in the prevention and even treatment of atherosclerosis. Antioxidant application has 
also been suggested as an adjunct to hypolipidemic therapy to improve the impact of these drugs 
on coronary artery disease. Production of oxidized LDL (Ox-LDL) is a key factor in 
atherosclerosis. It has also been suggested that antioxidants are able to suppress oxidative 
modification of LDL. Hence, antioxidant availability in hyperlipidemic subjects has been 
suggested to help in preventing the course of problem [88]. In this regard, most medicinal plants 
and functional foods effective on hyperlipidemia, act in part, through antioxidant activity [88]. 
  
 
 
Table1. Mechanisms actions of medicinal plants on atherosclerosis 
Plants Administration 
method 
Study design Main findings Reference 
PPARs 
Pandanus 
tectorius 
Oral Hyperlipidemic 
hamsters 
Increased 
expression of 
hepatic AMPK, 
PPARα, LPL, 
ACO, HSL, 
PPARγ, and 
CPT1. 
[35] 
Rheum 
undulatum 
Oral Hyperlipidemic mice Increased 
hepatic PPARα 
[36] 
and CPT1 
Mulberry, 
Korean red 
ginseng and 
Banana 
Oral Diabetes in db/db mice Decreased blood 
glucose, insulin, 
TG, and HbA1c 
and increased 
expression of 
PPARα in liver 
and PPARγ in 
adipose tissue 
[37] 
 
Astragalus 
membranaceus 
and  Pueraria 
thomsonii 
Addition to cell 
culture medium 
Culture medium 
containing cervical 
carcinoma (Hela) cells 
and HepG2. 
Increased 
activity of        
PPARα and      
PPARγ 
[38] 
Salacia oblonga Oral Rats Increased liver 
weight and 
hepatic PPARα 
activity 
[39] 
Berberine Oral Diabetic hamsters Increased 
expression of 
hepatic PPARα 
and LXRα 
[40] 
Cornifructus Oral Hypercholesterolemic 
rats 
Decreased   
atherogenic 
index and TC 
and increased 
hepatic PPARα 
expression and 
excretion of bile 
acids 
[41] 
Mulberry   
(Morus alba) 
Oral Hypercholesterolemic 
mice 
Increased 
expression of 
hepatic PPAR-α 
and decreased 
expression of 
genes for 
cholesterol 
[42] 
biosynthesis e.g. 
CYP51 
HMG-COA reductase 
Gypenoside Oral Hypercholesterolemic 
rats 
Decreased TC, 
TG, GSH-Px, 
SOD, CAT and 
MDA in serum 
and hepatic 
HMG-CoA 
reductase 
activity 
[60] 
Aconitum 
heterophyllum 
Oral Obese rats Decreased level 
of TC, TG, and 
ApoB, and 
hepatic HMG-
CoA reductase 
activity and 
increased serum 
HDL-C and 
ApoA and 
LCAT activity 
 
[61] 
Ananas Comusus Oral Hyperlipidemic mice Decreased 
activity of 
HMG-CoA 
reductase and PL 
and increased 
activity of LPL 
[63] 
Enicostemma 
littorale 
Oral Hyperlipidemic rats Inhibited HMG-
CoA reductase 
and decreased 
TG and TC and 
increased 
excretion of 
esterol bile acids 
[64] 
Terminalia 
arjuna 
Oral Hyperlipidemic rats Decreased TC, 
TG, LDL-C, 
VLDL-C and 
HMG-CoA 
reductase 
activity and 
increased LCAT 
and LPL 
[65] 
Aloe vera Oral Hyperlipidemic rats Decreased TC, 
TG, VLDL-C,  
atherogenic 
index LDL-C, 
and HMG-CoA 
reductase and 
increased HDL 
[66] 
Green tea Oral Rats fed with the diet 
containing 6% fructose 
Decreased 
expression of 
FAS, SCP1, 
ABCA1, HMG-
CoA reductase, 
and NPC1L1 
[68] 
Black        
chokeberry 
(Aronia 
melanocarpa) 
Addition to cell 
culture medium 
 
Culture medium 
containing  Caco-2 
(Human colorectal 
adenocarcinoma cell) 
Decreased 
expression of  
HMG-CoA 
reductase, FAS, 
ABCA1, 
ACOX1 
[69] 
inflammatory biomarkers 
Citrus flavonoids 
(naringin and 
naringenin) 
Oral Hypercholestremic 
rabbits 
Decreased 
expression of 
VCAM-1 and 
MCP-1 
[21] 
Virgin olive oil Oral 
 
Patient with 
atherosclerosis 
Decreased 
expression of 
CRP, IL-6 and 
endothelial and 
[23] 
monocyte 
adhesion 
molecules and 
chemokines 
Salvia 
miltiorrhiza 
Addition to cell 
culture medium 
Cell cultures of human 
aortic smooth muscle 
cells 
Decreased 
expression of 
MMP-9, NF-κB 
[22] 
Salvia 
miltiorrhiza 
Addition to cell 
culture medium 
ApoE-/-mice and cell 
culter of human aortic 
smooth muscle cells 
Inhibition of 
MMP-9 
[24] 
 
Bu-shen- Ning-
Xin Decoction 
Addition to cell 
culture medium 
Culture medium 
containing human 
umbilical vein 
endothelial cells 
Decreased 
Expression of 
NF-κB, MCP-1,  
VCAM-1 and E-
selectin 
[25] 
Gastredia elata Addition to cell 
culture medium 
 
Culture medium 
containing human 
umbilical vein 
endothelial cells 
Inhibition of 
MMP-2/-9 
activity 
[26] 
Ginkgo biloba Oral Hypercholestremic 
rabbits and 
Hypercholestremic rats 
Decreased 
Expression of 
IL-1β and 
decreased 
growth of 
VSMC and 
decreased 
expression of 
IL-1β, TNF-α     
dna                 
IL-10 
[27] 
ABCA and ABCG 
Brazilian red 
propolis 
Addition to cell 
culture  medium 
Cell culture Increased 
expression of 
PPARγ , LXR 
ApoA-1 and 
activity of 
ABCA1 
[53] 
Hibiscus 
salodariffa 
Addition to cell 
culture  medium 
Culture medium 
containing murine 
macrophage cell line 
Increased 
expression of 
LXRα/ABCA1 
[54] 
Xuemai ning Oral Hypercholesterolemic 
rabbits 
Increased 
expression of 
ABCA1 
[55] 
Crataegus 
pentaegyna 
Oral Hypercholesterolemic 
rats 
Increased 
expression 
ABCA1, LXRα, 
PPARα 
[56] 
Allium sativum Addition to cell 
culture  medium 
Culture medium 
containing macrophage 
cells 
Increased  
expression of 
ABCA1 
[57] 
 
SREBPs 
Berberine Oral Diabetic hamsters Decreased 
expression of 
SREBPs 
[40] 
Green tea  Rats fed with diet 
containing 6% fructose 
Decreased 
expression of 
SREBP-1c 
[68] 
Black        
chokeberry 
(Aronia 
melanocarpa) 
Addition to cell 
culture medium 
Culture medium 
containing  Caco-2 
(Human colorectal 
adenocarcinoma cell) 
Decreased 
expression of 
SREBP-2 
[69] 
Mulberry  Oral Hyperlipidemic mice Decreased 
expression of 
[42] 
(Morus alba) SREBP-1 
Aloe vera Oral C57BL/6J mice Decreased 
expression of 
FAS, SREBP-1a, 
and GPAT 
[72] 
Adiponectin 
Momordica 
charantia 
Addition to cell 
culture medium 
Culture medium 
containing 
3T3-L1 cells 
Increased 
expression of 
adiponectin 
[79] 
Allium sativum Oral 
 
Petient with 
Atherosclerosis 
Increased levels 
of adiponectin 
[80] 
Irvingia 
gabonensis 
Addition to cell 
culture medium 
Culture medium 
containing 
3T3-L1 cells 
Increased 
expression of 
adiponectin 
[81] 
Radix astragli 
and Astragalus 
membranaceus 
Oral Obese mice Increased levels 
of adiponectin 
[81, 82] 
Green tea Oral Hyperlipidemic mice Increased 
concentration of 
adiponectin 
[83] 
Sasa borealis Oral 
 
Obese C57/BL6J mice.   
 
Increased levels 
of adiponectin 
[84] 
Ganoderma 
lucidum 
Addition to cell 
culture medium 
Murine Pre-adipocyte 
Cell Line, 3T3-L1 
ptr_3242 202..207 
Increased 
expression of 
adiponectin 
[85] 
Brassica  rapa, 
Phaseolus 
vulgaris, 
Brassica rapa, 
Glycine max, 
Spinacia 
oleracea, Pisum 
sativum, 
Raphanus 
sativus, Arctium 
lappa, 
Momordica 
charantia and 
Brassica 
oleracea 
Addition to cell 
culture medium 
3T3-L 1 Adipocyte s Increased activity 
of adiponectin 
[86] 
 
ABCA1: ATP-binding cassette transporter A1; ABCG: ATP-binding cassette transporter G; ACOX1: acyl-CoA 
oxidases1; CRP:  C-reactive protein; AMPK: 5' Adenosine monophosphate-activated protein kinase; ACO: 
Acyl-CoA oxidase; CPT1: Carnitine palmitoyltransferase 1; HSL: Hormone sensitive lipase; LPL: Lipoprotein 
lipase; LXRα: Liver X receptor α; TC: Total cholesterol; CYP51: Cytochrome P450, family 51; GSH-Px: 
Glutathion peroxidase, SOD; Superoxide dismutase, MDA: Malondialdehyde; ApoB: Apolipoprotein B; HMG- 
COA Reductase: 3-Hydroxy-3-methyl-glutaryl-coenzyme A reductase; HDL-C: High-density lipoprotein 
cholesterol; LCAT: Lecithin cholesterol acyltransferase; VLDL-C: Very low-density lipoprotein cholesterol; 
FAS: Fatty acid synthase; SCP1: Sterol carrier and lipid transfer proteins; NPC1L1: Niemann-Pick C1-Like 1; 
TG: Triglyceride; VCAM-1: Vascular cell adhesion molecule-1; MCP-1: Monocyte chemoattractant protein-1; 
SREBPs: Sterol regulatory element-binding proteins; PPARs: Peroxisome proliferator-activated receptor; IL-6: 
Interloukin 6; MMP-9: Matrix metalloproteinase; VSMC: Vascular smooth muscle cells; SREBP: sterol 
regulatory element binding protein ; GPAT: Glycerol phosphate acyltransferase  
 
4. CONCLUSION 
Currently, atherosclerosis is a major health issue in most communities. Due to the convenience 
of access, relatively fewer side effects, and lower costs, medicinal plants can serve as alternatives 
or adjuncts to synthetic drugs. Overall, medicinal plants have been reported to benefit the 
treatment of atherosclerosis through different mechanisms including the regulation of expression 
and levels of inflammatory factors, stimulation of PPARs, inhibition of HMG-CoA reductase, 
promotion of ABCA1 and ABCG, facilitation of adiponectin, reduction of SREBPs and 
antioxidant activity. The majority of studies have investigated the effects of these plants in 
treating atherosclerosis but fewer studies have been conducted to investigate the mechanisms of 
their action on this disease. Gathering knowledge concerning such mechanisms can only assist in 
the development of novel drugs. Further research is therefore warranted to investigate the effects 
of medicinal plants and their chemical constituents in treating atherosclerosis.    
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